Sandy Spring Bank »

Recro Pharma shares owned by Sandy Spring Bank

Quarter-by-quarter ownership of Recro Pharma (SCTL) shares owned by Sandy Spring Bank from 13F filings

Historical chart of Sandy Spring Bank investment in Recro Pharma

Tip: Access up to 7 years of quarterly data

All positions including Recro Pharma held by Sandy Spring Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recro Pharma by Sandy Spring Bank

Quarter filed Position value Share count Share price at filing
2023-12-31 $701 2.0k 0.35
2023-09-30 $939 2.0k 0.47

More positions owned by Sandy Spring Bank

Ishares S&p Midcap 400 Index Core S&p Mcp Etf (IJH)
Ishares S&p 500 Index Fund Core S&p500 Etf (IVV)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares S&p Smallcap 600 Index Fund Core S&p Scp Etf (IJR)
Spdr S&p 500 Etf Trust Tr Unit (SPY)
Midcap 400 Spdr Trust Series 1 Utser1 S&pdcrp (MDY)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Ishares Core S&p Value Etf Core S&p Us Vlu (IUSV)
Ishares Core S&p Us Growth Core S&p Us Gwt (IUSG)
Alphabet Inc-cl C Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Wisdomtree Tr Us Midcap Divid (DON)
Berkshire Hathaway Inc B Cl B New (BRK.B)

View all positions for Sandy Spring Bank

Top funds holding Recro Pharma

First Light Asset Management
AWM Investment Company
Royce & Associates
Samjo Management
Vanguard Group
OV Management
Caligan Partners
First Eagle Investment Management
Alyeska Investment Group
Nantahala Capital Management
Clear Harbor Asset Management
Titleist Asset Management
Citadel Advisors
Millennium Management
Global Retirement Partners

View all funds holding Recro Pharma